7Baggers
Quarterly
Annual
    Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-06-30 2024-03-31 2023-12-31 2023-06-30 2023-03-31 2022-12-31 2022-06-30 2022-03-31 2021-12-31 2020-12-31 2019-12-31 
                  
      first nine months
    		              
      cash flows from operating activities
    		              
      net income
    		444,000,000 473,000,000 1,831,000,000 3,167,000,000 1,334,000,000 -523,000,000 3,679,000,000 1,663,000,000 1,259,000,000 -2,481,000,000 -3,119,000,000   -1,672,000,000 
      depreciation and tooling amortization
    		3,747,000,000 1,848,000,000 1,931,000,000 3,795,000,000 1,881,000,000 2,012,000,000 3,775,000,000 1,897,000,000 1,973,000,000 3,774,000,000 1,857,000,000 1,840,000,000 2,081,000,000 2,379,000,000 
      other amortization
    		-929,000,000 -464,000,000 -481,000,000 -772,000,000 -376,000,000 -314,000,000 -554,000,000 -272,000,000 -273,000,000 -608,000,000 -310,000,000 -324,000,000 -356,000,000 -308,000,000 
      provision for credit and insurance losses
    		323,000,000 161,000,000 142,000,000 317,000,000 126,000,000 89,000,000 212,000,000 83,000,000 116,000,000 -107,000,000 -66,000,000    
      pension and other postretirement employee benefits
    		187,000,000 94,000,000 -540,000,000 201,000,000 166,000,000 2,026,000,000 612,000,000 303,000,000       
      equity method investment losses and impairments in excess of dividends received
    		261,000,000 -14,000,000             
      foreign currency adjustments
    		62,000,000 38,000,000 -69,000,000 173,000,000 -12,000,000 -135,000,000 -97,000,000 -94,000,000 44,000,000 60,000,000 32,000,000 184,000,000 -204,000,000 -103,000,000 
      net realized and unrealized losses on cash equivalents, marketable securities, and other investments
    		-43,000,000 -32,000,000 17,000,000 8,000,000 29,000,000 18,000,000 163,000,000 51,000,000 153,000,000 7,974,000,000 5,454,000,000    
      stock compensation
    		275,000,000 121,000,000 107,000,000 275,000,000 126,000,000 110,000,000 238,000,000 100,000,000 59,000,000 170,000,000 67,000,000 43,000,000 29,000,000 -10,000,000 
      provision for deferred income taxes
    		212,000,000 -54,000,000 679,000,000 206,000,000 -28,000,000 -1,604,000,000 3,000,000 17,000,000 -353,000,000 -1,160,000,000 -1,053,000,000    
      decrease in finance receivables
    		2,927,000,000 2,427,000,000 -1,560,000,000 -1,865,000,000 -1,121,000,000 -3,593,000,000 -1,473,000,000 -656,000,000 -3,959,000,000 -4,611,000,000 -2,192,000,000    
      decrease in accounts receivable and other assets
    		-3,500,000,000 -1,294,000,000 -451,000,000 -1,603,000,000 -806,000,000 345,000,000 -1,793,000,000 -732,000,000 1,187,000,000 -1,856,000,000 -956,000,000    
      decrease in inventory
    		-1,476,000,000 -2,677,000,000 2,365,000,000 -1,845,000,000 -3,154,000,000 3,010,000,000 -3,354,000,000 -1,967,000,000 1,584,000,000 -2,507,000,000 -2,755,000,000    
      increase in accounts payable and accrued and other liabilities
    		7,293,000,000 3,020,000,000 -961,000,000 5,269,000,000 3,333,000,000 634,000,000 6,134,000,000 2,323,000,000 -1,185,000,000 3,180,000,000 1,714,000,000    
      other
    		213,000,000 32,000,000 89,000,000 -309,000,000 41,000,000 369,000,000 165,000,000 95,000,000 79,000,000 118,000,000 132,000,000 -158,000,000 25,000,000 85,000,000 
      net cash from operating activities
    		9,996,000,000 3,679,000,000 3,028,000,000 6,893,000,000 1,385,000,000 2,492,000,000 7,835,000,000 2,800,000,000 1,178,000,000 1,863,000,000 -1,084,000,000    
      cash flows from investing activities
    		              
      capital spending
    		-3,906,000,000 -1,818,000,000 -2,498,000,000 -4,194,000,000 -2,094,000,000 -2,295,000,000 -3,729,000,000 -1,780,000,000 -2,065,000,000 -3,069,000,000 -1,370,000,000 -1,772,000,000 -1,531,000,000 -2,274,000,000 
      acquisitions of finance receivables and operating leases
    		-24,438,000,000 -11,611,000,000 -14,778,000,000 -29,542,000,000 -14,829,000,000 -14,343,000,000 -26,231,000,000 -12,543,000,000 -12,545,000,000 -20,749,000,000 -10,278,000,000 -13,686,000,000 -12,428,000,000 -14,434,000,000 
      collections of finance receivables and operating leases
    		22,542,000,000 10,983,000,000 11,304,000,000 22,530,000,000 11,238,000,000 10,835,000,000 22,517,000,000 11,170,000,000 10,600,000,000 24,139,000,000 11,988,000,000 12,654,000,000 12,210,000,000 12,328,000,000 
      purchases of marketable securities and other investments
    		-4,440,000,000 -2,433,000,000 -3,799,000,000 -6,069,000,000 -2,985,000,000 -2,691,000,000 -4,860,000,000 -2,545,000,000 -3,343,000,000 -8,065,000,000 -4,319,000,000 -4,248,000,000 -12,223,000,000 -5,105,000,000 
      sales and maturities of marketable securities and other investments
    		5,593,000,000 3,617,000,000 1,735,000,000 6,812,000,000 3,579,000,000 2,316,000,000 7,584,000,000 4,413,000,000 2,909,000,000 11,257,000,000 7,115,000,000 4,790,000,000 7,993,000,000  
      settlements of derivatives
    		-104,000,000 -180,000,000 -94,000,000 -237,000,000 -184,000,000 69,000,000 -32,000,000 -41,000,000 -139,000,000 156,000,000 212,000,000 -28,000,000 84,000,000 -277,000,000 
      capital contributions to equity method investments
    		-138,000,000 -3,000,000 -123,000,000 -1,299,000,000 -639,000,000 -1,118,000,000 -1,047,000,000 -699,000,000       
      returns of capital from equity method investments
    		1,700,000,000 1,700,000,000             
      net cash from investing activities
    		-3,011,000,000 210,000,000 -6,861,000,000 -11,921,000,000 -5,880,000,000 -7,409,000,000 -6,157,000,000 -1,977,000,000 -4,972,000,000 4,142,000,000 3,315,000,000    
      cash flows from financing activities
    		              
      cash payments for dividends and dividend equivalents
    		-1,793,000,000 -1,196,000,000 -596,000,000 -1,925,000,000 -1,326,000,000 -601,000,000 -3,794,000,000 -3,193,000,000 -599,000,000 -807,000,000 -405,000,000 -400,000,000 0 -595,000,000 
      purchases of common stock
    		  -150,000,000 -244,000,000          0 
      net changes in short-term debt
    		-1,110,000,000 -564,000,000 957,000,000 -1,008,000,000 -1,201,000,000 -597,000,000 -658,000,000 -2,211,000,000 3,810,000,000 595,000,000 -614,000,000 1,705,000,000 524,000,000 -290,000,000 
      proceeds from issuance of long-term debt
    		20,469,000,000 11,979,000,000 13,733,000,000 28,960,000,000 16,488,000,000 15,077,000,000 26,401,000,000 13,912,000,000 12,615,000,000 18,868,000,000 12,489,000,000 8,601,000,000 11,575,000,000 11,899,000,000 
      payments of long-term debt
    		-24,828,000,000 -16,223,000,000 -10,117,000,000 -25,145,000,000 -14,225,000,000 -10,146,000,000 -22,213,000,000 -12,242,000,000 -8,260,000,000 -24,697,000,000 -12,975,000,000    
      net cash from financing activities
    		-7,408,000,000 -6,120,000,000 3,790,000,000 384,000,000 -458,000,000 3,383,000,000 -461,000,000 -3,874,000,000 7,055,000,000 -6,240,000,000 -1,661,000,000    
      effect of exchange rate changes on cash, cash equivalents, and restricted cash
    		483,000,000 118,000,000 -493,000,000 -240,000,000 -171,000,000 10,000,000 66,000,000 70,000,000 358,000,000 -368,000,000 -24,000,000 -77,000,000 385,000,000 199,000,000 
      net increase in cash, cash equivalents, and restricted cash
    		60,000,000 -2,113,000,000 -536,000,000 -4,884,000,000 -5,124,000,000 -1,524,000,000 1,283,000,000 -2,981,000,000 3,619,000,000 -603,000,000 546,000,000    
      cash, cash equivalents, and restricted cash at beginning of period
    		23,190,000,000 23,190,000,000 0 25,110,000,000 25,110,000,000 0 25,340,000,000 25,340,000,000 0 20,737,000,000 20,737,000,000 0 0 0 
      cash, cash equivalents, and restricted cash at end of period
    		23,250,000,000 21,077,000,000 -536,000,000 20,226,000,000 19,986,000,000 -1,524,000,000 26,623,000,000 22,359,000,000 3,619,000,000 20,134,000,000 21,283,000,000 -6,887,000,000 1,463,000,000 -2,940,000,000 
      first half
    		              
      first quarter
    		              
      proceeds from sale of business
    		        14,000,000   0 0  
      equity method investment dividends received in excess of losses and impairments
    		   -124,000,000 -154,000,000 38,000,000 142,000,000 -7,000,000 349,000,000 171,000,000 199,000,000    
      losses on extinguishment of debt
    		        0      
      net loss on changes in investments in affiliates
    		     10,000,000 -17,000,000 -4,000,000 10,000,000 146,000,000 125,000,000    
      held-for-sale impairment charges
    		            2,000,000 5,000,000 
      brazil manufacturing exit non-cash charges
    		              
      held for sale impairment charges
    		              
      pension and other post-retirement employee benefits
    		         -400,000,000 -213,000,000  1,481,000,000  
      net income/
    		           12,273,000,000 -2,791,000,000  
      55
    		              
      benefit from/(benefit from) credit and insurance losses
    		              
      equity investment dividends received in excess of (earnings)/losses
    		           21,000,000 -2,000,000  
      net realized and unrealized (gains)/losses on cash equivalents, marketable securities, and other investments
    		              
      net
    		           -14,000,000   
      benefit from deferred income taxes
    		           -1,215,000,000 -1,247,000,000 -967,000,000 
      decrease/
    		           -852,000,000 1,098,000,000 -1,238,000,000 
      decrease/(increase) in accounts receivable and other assets
    		           188,000,000 -137,000,000 207,000,000 
      decrease/(increase) in inventory
    		           1,351,000,000 350,000,000 1,996,000,000 
      increase/(decrease) in accounts payable and accrued and other liabilities
    		           475,000,000 2,951,000,000 34,000,000 
      net cash provided by/(used in) operating activities
    		           3,531,000,000 4,539,000,000 2,900,000,000 
      net cash provided by/(used in) investing activities
    		           -2,263,000,000 -5,745,000,000 -5,350,000,000 
      net cash provided by/(used in) financing activities
    		           -8,078,000,000 2,284,000,000 -689,000,000 
      net increase/(decrease) in cash, cash equivalents, and restricted cash
    		           -6,887,000,000 1,463,000,000 -2,940,000,000 
      increase/(decrease) in benefit from credit and insurance losses
    		              
      net unrealized
    		              
      principal payments on long-term debt
    		            -9,873,000,000 -11,650,000,000 
      benefit from credit and insurance losses
    		            63,000,000 121,000,000 
      net (gain)/loss on changes in investments in affiliates
    		             17,000,000 
      sales and maturities of marketable and other investments
    		              
      equity investment (earnings)/losses in excess of dividends received
    		              
      purchases of marketable and other securities
    		              
      sales and maturities of marketable and other securities
    		              
      cash, cash equivalents, and restricted cash at january 1
    		              
      cash, cash equivalents, and restricted cash at march 31
    		              
      cash dividends
    		              
      cash, cash equivalents, and restricted cash at september 30
    		              
      cash, cash equivalents, and restricted cash at june 30
    		              
      purchases of equity and debt securities
    		              
      sales and maturities of equity and debt securities
    		              
      proceeds from issuance of other debt
    		              
      principal payments on other debt
    		              
      effect of exchange rate changes on cash and cash equivalents
    		              
      net increase/(decrease) in cash and cash equivalents
    		              
      cash and cash equivalents at january 1
    		              
      cash and cash equivalents at june 30
    		              
      cash and cash equivalents at march 31
    		              
      purchases of marketable securities
    		              
      sales and maturities of marketable securities
    		              
      cash flows from operating activities of continuing operations
    		              
      cash flows from investing activities of continuing operations
    		              
      purchases of securities
    		              
      sales and maturities of securities
    		              
      cash change due to initial consolidation of businesses
    		              
      cash flows from financing activities of continuing operations
    		              
      changes in short-term debt
    		              
      capital expenditures
    		0 0 0 0 0 0 0 0 0 0 0    
      free cash flows
    		9,996,000,000 3,679,000,000 3,028,000,000 6,893,000,000 1,385,000,000 2,492,000,000 7,835,000,000 2,800,000,000 1,178,000,000 1,863,000,000 -1,084,000,000    
      acquisitions of retail and other finance receivables and operating leases
    		              
      collections of retail and other finance receivables and operating leases
    		              
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.